# US 2010/0167392 A1 · Factor viii compositions and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167392 A1
- Document ID: US20100167392A1
- Status: Published application
- Kind: A1
- Application number: 12/572,363
- Filed: 2009-10-02
- Published: 2010-07-01
- Earliest claimed: 2003-10-31
- Assignees: University of Maryland, Baltimore
- Inventors: Evgueni L. SAENKO; Andrey G. Sarafanov; Natalya M. Ananyeva
- Web page: https://patentgrep.com/patent/US20100167392A1

## CPC

- C07K 14/755: Factors VIII {, e.g. factor VIII C (AHF), factor VIII Ag (VWF)}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides methods of increasing the half-life and/or specific activity of factor VIII. More specifically, the invention provides methods of increasing the half-life and/or specific activity of factor VIII by substituting one or more amino acids in the A2 domain. It further provides methods for producing such factor VIII mutants. The invention also provides polynucleotides encoding the mutant factor VIII, and methods of treating hemophilia using the polypeptides and polynucleotides of the invention.

## Claims

### Claim at position 1

1-4. (canceled)

### Claim 5

An isolated polynucleotide encoding a mutant factor VIII comprising the amino acid sequence of SEQ ID NO:5, further comprising an amino acid substitution at position Lys(466) and/or position Arg(471) and optionally at one or more positions selected from the group consisting of Lys(380), Arg(484), Tyr(487), Ser(488), Arg(489), Arg(490), His(497), His(499), Lys(523), and Lys(556).

### Claim at position 3

6-10. (canceled)

### Claim 11

An isolated polynucleotide encoding a mutant factor VIII comprising the amino acid sequence of SEQ ID NO:5, further comprising an amino acid substitution at position Lys(466) and/or position Arg(471) and optionally at one or more positions selected from the group consisting of Lys(380), Arg(484), Tyr(487), Ser(488), Arg(489), Arg(490), His(497), His(499), Lys(523), and Lys(556), further comprising an amino acid substitution at one or more additional positions in the A2 domain.

### Claim at position 5

12-16. (canceled)

### Claim 17

A polynucleotide encoding a mutant factor VIII comprising the amino acid sequence of SEQ ID NO:5, further comprising a substitution at one or more positions selected from the group consisting of Lys(377), His(378), and Lys(466), and optionally at one or more positions selected from the group consisting of Lys (380), Ser(488), Arg(489), Arg(490), Leu(491), Lys(493), Lys(496), His(497), His(499), Lys(512), Lys(523), and Lys(556).

### Claim at position 7

18-22. (canceled)

### Claim 23

A polynucleotide encoding a mutant factor VIII comprising the amino acid sequence of SEQ ID NO:5, further comprising a substitution at one or more positions selected from the group consisting of Lys(377), His(378), and Lys(466), and optionally at one or more positions selected from the group consisting of Lys(380), Ser(488), Arg(489), Arg(490), Leu(491), Lys(493), Lys(496), His(497), His(499), Lys(512), Lys(523), and Lys(556), further comprising the amino acid substitution at one or more additional positions in the A2 domain.

### Claim at position 9

24-32. (canceled)

### Claim 33 (depends on 5, 11, 17, 23)

The polynucleotide of any one of claims 5, 11, 17 or 23 wherein said polynucleotide is in a vector.

### Claim 34 (depends on 33)

The polynucleotide of claim 33, wherein said vector is an expression vector capable of expressing said mutant factor VIII.

### Claim 35 (depends on 5, 11, 17, 23)

The polynucleotide of any one of claims 5, 11, 17 or 23 wherein said polynucleotide is a genetic construct operatively linked to a promoter sequence and to a polyadenylation signal sequence.

### Claim 36 (depends on 5, 11, 17, 23)

The polynucleotide of any one of claims 5, 11, 17 or 23 wherein said polynucleotide is in a host cell.
